-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Zenas BioPharma, Raises Price Target to $22

Benzinga·05/14/2026 17:27:36
Listen to the news
Morgan Stanley analyst Judah Frommer maintains Zenas BioPharma (NASDAQ:ZBIO) with a Equal-Weight and raises the price target from $21 to $22.